ArticleOncology research2019

Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway.

Liwei Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.